These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

161 related items for PubMed ID: 21187472

  • 1. Targeting KRAS mutation-bearing lung cancer in vivo by pulmonary surfactant-adenovirus-mediated gene transfer.
    Fukazawa T, Maeda Y, Matsuoka J, Ono T, Mominoki K, Yamatsuji T, Shigemitsu K, Morita I, Murakami I, Tanaka H, Durbin ML, Naomoto Y.
    Anticancer Res; 2010 Dec; 30(12):4925-35. PubMed ID: 21187472
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Anti-tumor efficacy of a transcriptional replication-competent adenovirus, Ad-OC-E1a, for osteosarcoma pulmonary metastasis.
    Li X, Jung C, Liu YH, Bae KH, Zhang YP, Zhang HJ, Vanderputten D, Jeng MH, Gardner TA, Kao C.
    J Gene Med; 2006 Jun; 8(6):679-89. PubMed ID: 16570242
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Conditionally replicative adenovirus driven by the human telomerase promoter provides broad-spectrum antitumor activity without liver toxicity.
    Irving J, Wang Z, Powell S, O'Sullivan C, Mok M, Murphy B, Cardoza L, Lebkowski JS, Majumdar AS.
    Cancer Gene Ther; 2004 Mar; 11(3):174-85. PubMed ID: 14726958
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Treatment of hepatocellular carcinoma with a novel gene-viral therapeutic system CNHK300-murine endostatin].
    Li GC, Nie MM, Yang JM, Su CQ, Sun LC, Qian YZ, Sham J, Fang GE, Wu MC, Qian QJ.
    Zhonghua Yi Xue Za Zhi; 2004 Jun 02; 84(11):943-8. PubMed ID: 15329284
    [Abstract] [Full Text] [Related]

  • 9. Oncolytic adenovirus that overproduces ADP and replicates selectively in tumors due to hTERT promoter-regulated E4 gene expression.
    Kuppuswamy M, Spencer JF, Doronin K, Tollefson AE, Wold WS, Toth K.
    Gene Ther; 2005 Nov 02; 12(22):1608-17. PubMed ID: 16034456
    [Abstract] [Full Text] [Related]

  • 10. Therapeutic efficacy of an hTERT promoter-driven oncolytic adenovirus that expresses apoptin in gastric carcinoma.
    Liu L, Wu W, Zhu G, Liu L, Guan G, Li X, Jin N, Chi B.
    Int J Mol Med; 2012 Oct 02; 30(4):747-54. PubMed ID: 22842823
    [Abstract] [Full Text] [Related]

  • 11. A novel oncolytic adenovirus targeting to telomerase activity in tumor cells with potent.
    Zou W, Luo C, Zhang Z, Liu J, Gu J, Pei Z, Qian C, Liu X.
    Oncogene; 2004 Jan 15; 23(2):457-64. PubMed ID: 14724574
    [Abstract] [Full Text] [Related]

  • 12. Increased safety with preserved antitumoral efficacy on hepatocellular carcinoma with dual-regulated oncolytic adenovirus.
    Zhang Q, Chen G, Peng L, Wang X, Yang Y, Liu C, Shi W, Su C, Wu H, Liu X, Wu M, Qian Q.
    Clin Cancer Res; 2006 Nov 01; 12(21):6523-31. PubMed ID: 17085667
    [Abstract] [Full Text] [Related]

  • 13. Inhibition of intratracheal lung cancer development by systemic delivery of E1A.
    Chang JY, Xia W, Shao R, Hung MC.
    Oncogene; 1996 Oct 03; 13(7):1405-12. PubMed ID: 8875978
    [Abstract] [Full Text] [Related]

  • 14. Adenovirus-mediated and tumor-specific transgene expression of the sodium-iodide symporter from the human telomerase reverse transcriptase promoter enhances killing of lung cancer cell line in vitro.
    Shi YZ, Zhang J, Liu ZL, Du SY, Shen YM.
    Chin Med J (Engl); 2010 Aug 05; 123(15):2070-6. PubMed ID: 20819544
    [Abstract] [Full Text] [Related]

  • 15. Etoposide enhances antitumor efficacy of MDR1-driven oncolytic adenovirus through autoupregulation of the MDR1 promoter activity.
    Su BH, Shieh GS, Tseng YL, Shiau AL, Wu CL.
    Oncotarget; 2015 Nov 10; 6(35):38308-26. PubMed ID: 26515462
    [Abstract] [Full Text] [Related]

  • 16. Immune gene-viral therapy with triplex efficacy mediated by oncolytic adenovirus carrying an interferon-gamma gene yields efficient antitumor activity in immunodeficient and immunocompetent mice.
    Su C, Peng L, Sham J, Wang X, Zhang Q, Chua D, Liu C, Cui Z, Xue H, Wu H, Yang Q, Zhang B, Liu X, Wu M, Qian Q.
    Mol Ther; 2006 May 10; 13(5):918-27. PubMed ID: 16497559
    [Abstract] [Full Text] [Related]

  • 17. Oncolytic virotherapy for prostate cancer by E1A, E1B mutant adenovirus.
    Satoh M, Wang H, Ishidoya S, Abe H, Moriya T, Hamada H, Arai Y.
    Urology; 2007 Dec 10; 70(6):1243-8. PubMed ID: 18158069
    [Abstract] [Full Text] [Related]

  • 18. Antitumor activity of an oncolytic adenovirus-delivered oncogene small interfering RNA.
    Zhang YA, Nemunaitis J, Samuel SK, Chen P, Shen Y, Tong AW.
    Cancer Res; 2006 Oct 01; 66(19):9736-43. PubMed ID: 17018633
    [Abstract] [Full Text] [Related]

  • 19. Tumor-specific adenovirus-mediated PUMA gene transfer using the survivin promoter enhances radiosensitivity of breast cancer cells in vitro and in vivo.
    Wang R, Wang X, Li B, Lin F, Dong K, Gao P, Zhang HZ.
    Breast Cancer Res Treat; 2009 Sep 01; 117(1):45-54. PubMed ID: 18791823
    [Abstract] [Full Text] [Related]

  • 20. Tumor-specific therapeutic effect induced by an oncolytic adenoviral vector containing heat shock protein 70 and prodrug activation genes.
    Liu Y, Ye T, Sun D, Maynard J, Deisseroth A.
    Gene Ther; 2006 Aug 01; 13(16):1235-43. PubMed ID: 16617300
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.